Nav: Home

A new tactic for starving tumors

June 25, 2018

A tumor's goal is simple: to grow, grow, grow, by making more cancer cells. But that often means growing so fast that the oxygen supply gets scarce, at which point cells within the tumor start to suffocate. Without oxygen, these ever-dividing cells struggle to make enough aspartate, a crucial ingredient in many cellular processes.

That's the scenario worked out by the research group of Kivanç Birsoy, head of the Laboratory of Metabolic Regulation and Genetics at The Rockefeller University. It suggests that tumors in oxygen-starved tissues have an Achilles' heel--their already-undercut production of aspartate--that doctors could target with drugs. The researchers report their work in Nature Cell Biology this week.

Suffocation in a Petri dish

Scientists already knew that when certain tumors have outgrown their blood supply, they grow slowly under low-oxygen conditions. But it wasn't understood exactly why this happens. The oxygen molecule participates in a vast number of a cell's chemical reactions, any of which could be limiting its growth.

To zero in on the most important reactions, Javier Garcia-Bermudez, a postdoctoral associate in Birsoy's group, mimicked oxygen deprivation in cancer cells harvested from 28 patients--including cancers from blood, stomach, breast, colon and lung--that he cultured in the lab. Many of these cells exhibited stunted growth under low-oxygen-like conditions, but others were less sensitive, and some weren't bothered at all by the treatment.

In comparing these cells' production of chemicals, or metabolites, Garcia-Bermudez noticed that the most sensitive ones lost the amino acid aspartate under oxygen deprivation. Cells can't make aspartate without oxygen, but it seemed as if the resistant cells were able to obtain it from their environment.

In the sensitive cells, a lack of aspartate would affect not only the production of new proteins, but also several other processes that rely on aspartate, such as the synthesis of genetic material.

Birsoy says he was surprised to see that so much of the oxygen-deprivation problem came down to this one amino acid. He had expected many more metabolites would depend on oxygen supply.

Hitting tumors where it hurts

The researchers found there was something special about many of the cancers that resisted oxygen deprivation: they turned on a gene called SLC1A3 to suck up aspartate from their surroundings.

When Garcia-Bermudez turned on this gene in the lab-grown cancers that were normally sensitive to low oxygen, they grew faster.

The same was true when he transplanted the tumors into mice, providing further support for the idea that aspartate can be a limiting factor for tumor growth when oxygen is scarce. "This is something they're really starving for," says Birsoy.

The discovery might offer opportunities for creating drugs to stab cancers in this particular Achilles' heel, making them even hungrier for aspartate. There might be several ways to prevent cancer cells from getting aspartate, Birsoy suspects, by blocking their methods to make the amino acid or take it up from their surroundings.

If he is right, an anti-aspartate treatment might one day provide a supplement to typical chemotherapy and radiation, and it could potentially be effective for any type of tumor containing oxygen-starved areas. Those parts of tumors tend to resist typical chemo and radiation, Birsoy adds.

He envisions a sort of one-two punch: One treatment for the parts of a tumor that are well-supplied with oxygen, and an aspartate blocker for the rest.

That sort of drug combo is a long ways off, however. For starters, Birsoy now plans to investigate possible drugs that would interfere with aspartate production in the lab.
-end-


Rockefeller University

Related Cancer Cells Articles:

Cancer cells send signals boosting survival and drug resistance in other cancer cells
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
A protein that stem cells require could be a target in killing breast cancer cells
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
Single gene encourages growth of intestinal stem cells, supporting 'niche' cells -- and cancer
A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.
Prostate cancer cells grow with malfunction of cholesterol control in cells
Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem.
Immune therapy scientists discover distinct cells that block cancer-fighting immune cells
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
New system developed that can switch on immune cells to attack cancer cells
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.
Hybrid immune cells in early-stage lung cancer spur anti-tumor T cells to action
Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Sleep hormone helps breast cancer drug kill more cancer cells
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects.
Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor
Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.

Related Cancer Cells Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".